Starbucks fans across Canada are in for a magical treat starting tomorrow, October 22, with the launch of two new colourful witchy drinks inspired by Wicked.
According to Starbucks, the new limited-time seasonal beverages — Glinda's Pink Potion and Elphaba's Cold Brew — are part of a collaboration with Universal Pictures to celebrate the theatrical release of the highly anticipated Wicked movie next month. Both drinks will be available in cafes across Canada starting on Tuesday.
The first new Starbucks drink, Glinda's Pink Potion, described as "a delightfully pink creation," features the Mango Dragonfruit Refresher, hand-shaken with creamy coconut milk, ice and a scoop of freeze-dried dragonfruit. The drink is finished with non-dairy strawberry cold foam and colourful candy sprinkles, capturing Glinda's vibrant, "Popular" spirit.
You can order Elphaba's Cold Brew and Glinda's Pink Potion at Starbucks locations across Canada starting tomorrow.Starbucks | Handout
Elphaba's Cold Brew, on the other hand, is for those who like "Defying Gravity." This Starbucks Cold Brew comes with peppermint-flavoured syrup, topped with non-dairy matcha cold foam and sprinkled with green candy dust. Starbucks says the drink is inspired by Elphaba's bold energy and iconic green hue.
Starting November 7, select Starbucks stores will also offer Wicked-themed merch, including drinkware and gift cards, featuring Glinda's signature pink and Elphaba's bold green.
The new Wicked-inspired beverages will be available at Starbucks locations across Canada for a limited time, starting tomorrow, and Wicked itself hits theatres on November 22.
So, whether you're team Glinda or team Elphaba — or just looking to add a witchy twist to your October coffee order — these drinks are sure to bring a little bit of Oz to your next coffee run!
AI tools may have been used to support the creation or distribution of this content; however, it has been carefully edited and fact-checked by a member of Narcity's Editorial team. For more information on our use of AI, please visit our Editorial Standards page.